Inhibiting core enzymes of DNL, including citrate/isocitrate carrier (CIC), ATP-citrate lyase (ACLY), acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS), represents an attractive therapeutic strategy
When to Choose TB-500: Multi-Site, Post-Surgical, and Systemic Recovery TB-500 is the right choice when the recovery picture involves more than one location or when systemic inflammation is the primary barrier to healing
Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas
Davis-Dusenbery BN, Wu C, Hata A
Peptides for Gut Health in Silver Spring: Safety Profile & Considerations BPC-157 is often regarded as well-tolerated in preclinical and early clinical or anecdotal usage
doi: 10.1016/j.jtemb.2010.11.004